Member Info for desamax

(¥)

I wonder what the grant is being used for?

Down?

Thanks corp

When is the Jefferys presentation? Tomorrow or Thursday?

Anyone any idea of the timeframe for a potential buyer to get their feet under the table and then make the bold move ? Weeks, months, years?? Will TR1 be the only clue.

Seen worse last week with the same covid news. I’d say today’s made many nervous to but in, in fear of another big drop that never materialised.
GLA

1.465 on the ask on HL for over a million

https://www.medpagetoday.com/meetingcoverage/acr/89585

If this is a repost

https://www.fiercepharma.com/pharma/amgen-s-otezla-faces-threat-from-bms-psoriasis-candidate-analysts-say-but-safety-data-will

Back in the room :)

If they have found something would they be allowed to broadcast this to the world. Or could there be a NDA that’s stopping them.

https://sec.report/Document/0001564590-20-053253/

Commenting on the plans in relation to SRA737, Nick Glover, President and CEO of Sierra Oncology, said: "We recently reported compelling proof-of-concept clinical efficacy data for SRA737 at the 2019 ASCO Annual Meeting, demonstrating that this drug candidate has notable anti-cancer activity in multiple indications and a defined clinical path forward towards potential initial registration for the treatment of anogenital cancer, an indication with considerable unmet need."

Dr Glover continued: "While we continue to advance the assets in our DDR portfolio and view them as promising oncology drug candidates that warrant further development, we are prioritizing our resources on our lead drug, momelotinib. To support the continued development of SRA737 in the future, we intend to seek non-dilutive strategic options."

The unknown Chinese BIO , after seeing today’s news trying to negotiate a reduced milestone payment?

Thor = This

Thor to be the start of positive news flow, China’s due among all the other updates forthcoming.

With this SP turnaround, long may it continue

1.285 to sell, wanted stock

This from Kate Bingham in the Lancet is also very interesting, about prospects for a neutralising antibody ****tail. I understand AstraZeneca is aiming to deliver results in Jan, and that it could be a Covid-19 prophylaxis as well as treatment: "We also have an agreement with AstraZeneca to supply a neutralising antibody ****tail as a prophylactic treatment once clinical trials are completed and it is approved by regulators. This treatment will be provided in the short term for people who cannot receive a vaccine, such as people who are heavily immunosuppressed and cannot mount an immune response, or people who need immediate protection, such as health-care workers".
The above is a tweet from Peston